1. Home
  2. RCEL

as of 02-24-2026 4:00pm EST

$5.39
+$0.54
+11.13%
Stocks Health Care Medical/Dental Instruments Nasdaq

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Founded: N/A Country:
United States
United States
Employees: 226 City: VALENCIA
Market Cap: 132.0M IPO Year: N/A
Target Price: $7.17 AVG Volume (30 days): 196.9K
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $3.22 - $10.28 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 21.69% Revenue Growth (next year): 49.58%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

AI-Powered RCEL Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 70.49%
70.49%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Avita Medical Inc. News

RCEL Breaking Stock News: Dive into RCEL Ticker-Specific Updates for Smart Investing

All RCEL News

Share on Social Networks: